Search result for 'api facility'

Aurobindo Pharma's subsidiary, Apitoria Pharma, received 10 observations from the USFDA after an inspection of its API facility in Telangana. The observations are procedural in nature and will be...

Biocon's Bengaluru-based API facility received four observations from the USFDA following an inspection. The company plans to address the observations within the stipulated time.

Biocon's Q1 profit jumps six-fold to Rs 660 crore, driven by a one-time gain from the Biocon Biologics and Eris Lifesciences collaboration. Revenue also grew slightly.

Biocon Biologics receives approval from the EMA to manufacture biosimilar Bevacizumab at its Bengaluru facility, expanding capacity for European markets. The company also received GMP certificates...

Biocon received four observations from the USFDA after an inspection of its API facility in Visakhapatnam, Andhra Pradesh. The company will address the observations within the stipulated time.